JP2024119900A5 - - Google Patents

Download PDF

Info

Publication number
JP2024119900A5
JP2024119900A5 JP2024091467A JP2024091467A JP2024119900A5 JP 2024119900 A5 JP2024119900 A5 JP 2024119900A5 JP 2024091467 A JP2024091467 A JP 2024091467A JP 2024091467 A JP2024091467 A JP 2024091467A JP 2024119900 A5 JP2024119900 A5 JP 2024119900A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
promoter
casq2
patient
ryr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024091467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024119900A (ja
Filing date
Publication date
Priority claimed from IT102018000004253A external-priority patent/IT201800004253A1/it
Application filed filed Critical
Publication of JP2024119900A publication Critical patent/JP2024119900A/ja
Publication of JP2024119900A5 publication Critical patent/JP2024119900A5/ja
Pending legal-status Critical Current

Links

JP2024091467A 2018-04-05 2024-06-05 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法 Pending JP2024119900A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT102018000004253 2018-04-05
IT102018000004253A IT201800004253A1 (it) 2018-04-05 2018-04-05 Composizioni e metodi per il trattamento della tachicardia ventricolare polimorfa catecolaminergica dominante ereditaria.
PCT/IB2019/052817 WO2019193563A1 (en) 2018-04-05 2019-04-05 Compositions and methods for the treatment of dominantly-inherited catecholaminergic polymorphic ventricular tachycardia
JP2020552905A JP7500429B2 (ja) 2018-04-05 2019-04-05 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020552905A Division JP7500429B2 (ja) 2018-04-05 2019-04-05 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法

Publications (2)

Publication Number Publication Date
JP2024119900A JP2024119900A (ja) 2024-09-03
JP2024119900A5 true JP2024119900A5 (https=) 2025-02-12

Family

ID=66554445

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020552905A Active JP7500429B2 (ja) 2018-04-05 2019-04-05 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法
JP2024091467A Pending JP2024119900A (ja) 2018-04-05 2024-06-05 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020552905A Active JP7500429B2 (ja) 2018-04-05 2019-04-05 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法

Country Status (13)

Country Link
US (1) US20210030894A1 (https=)
EP (2) EP3773744B1 (https=)
JP (2) JP7500429B2 (https=)
AU (2) AU2019249374B2 (https=)
CA (1) CA3094141A1 (https=)
DK (1) DK3773744T3 (https=)
ES (1) ES2988961T3 (https=)
FI (1) FI3773744T3 (https=)
IL (2) IL315337A (https=)
IT (1) IT201800004253A1 (https=)
PL (1) PL3773744T3 (https=)
PT (1) PT3773744T (https=)
WO (1) WO2019193563A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3186584A1 (en) * 2020-07-08 2022-01-13 Children's Medical Center Corporation Mybpc3 polypeptides and uses thereof
CN113957075B (zh) * 2021-11-22 2023-04-07 百世诺(北京)医学检验实验室有限公司 突变的遗传性心律失常基因及其应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5766960A (en) 1987-07-27 1998-06-16 Australian Membrane And Biotechnology Research Institute Receptor membranes
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
DK0752248T3 (da) 1992-11-13 2000-11-13 Idec Pharma Corp Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
US5801030A (en) 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
US6268210B1 (en) 1998-05-27 2001-07-31 Hyseq, Inc. Sandwich arrays of biological compounds
US6232068B1 (en) 1999-01-22 2001-05-15 Rosetta Inpharmatics, Inc. Monitoring of gene expression by detecting hybridization to nucleic acid arrays using anti-heteronucleic acid antibodies
DE10120829A1 (de) 2000-04-27 2001-12-20 Max Delbrueck Centrum Sleeping Beauty, ein Transposonvektor mit breitem Wirtsbereich für die genetische Transformation bei Wirbeltieren
JP5170934B2 (ja) 2001-08-16 2013-03-27 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 改良dnaリポフェクションならびに/または徐放性プロドラッグおよび薬物療法のための試薬の合成と使用
ES2582091T3 (es) 2005-10-18 2016-09-09 Precision Biosciences Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
US7741529B1 (en) 2006-05-04 2010-06-22 Priori Silvia G Transgenic animal model for catecholaminergic polymorphic ventricular tachycardia (CPVT) and use thereof
EP1995316A1 (de) 2007-05-25 2008-11-26 Qiagen GmbH Verfahren zur schonenden Zellaufreinigung, Zellgewinnung und Transfektion von Zellen
EP2009095A1 (en) 2007-06-28 2008-12-31 Innovalor AG Method of generating glucose-responsive cells
EP2215223B1 (en) 2007-10-31 2013-05-01 Precision Biosciences, Inc. Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
WO2010085699A2 (en) 2009-01-23 2010-07-29 The Johns Hopkins University Mammalian piggybac transposon and methods of use
US8859517B2 (en) * 2011-08-08 2014-10-14 Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (CPVT)
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
WO2016083625A1 (en) * 2014-11-28 2016-06-02 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nucleic acid encoding triadin for the prevention and/or treatment of heart failure
WO2017141157A1 (en) * 2016-02-15 2017-08-24 Istituti Clinici Scientifici Maugeri Spa Sb Method of allele specific silencing for the treatment of autosomal dominant catecholaminergic polymorphic ventricular tachycardia (cpvt)

Similar Documents

Publication Publication Date Title
JP2024119900A5 (https=)
JP2022068181A5 (https=)
JP2021522173A5 (https=)
JP2023534999A5 (https=)
JP2024009857A5 (https=)
JP2020522269A5 (https=)
JP2021512649A5 (https=)
JP2020533959A5 (https=)
US20040180440A1 (en) Modified AAV
CN108348621A (zh) 用于基因治疗的经修饰的弗里德赖希共济失调基因及载体
JP2024523707A5 (https=)
JP2023537358A5 (https=)
JP2022511453A5 (https=)
JP2023524024A5 (https=)
KR102621134B1 (ko) 알데히드 데히드로게나제 결핍의 치료를 위한 유전자 요법
JP2022541793A5 (https=)
JP2023537980A5 (https=)
JP2023059858A5 (https=)
JP2024546103A (ja) Aavベクターを用いたジャンクトフィリン-2(jph2)遺伝子治療
US20250283111A1 (en) Recombinant adeno-associated viral vector for gene delivery
JP2021534766A5 (https=)
CN118159656A (zh) 肌营养不良的治疗
JP2024119900A (ja) 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法
TW202129002A (zh) 用於myh7關聯之心肌病之基因療法組合物及治療
JP2022554141A5 (https=)